Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-25-018384
Filing Date
2025-02-28
Accepted
2025-02-28 09:20:43
Documents
93
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0231788-10k_jasper.htm   iXBRL 10-K 1960848
2 JASPER THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY. ea023178801ex10-17_jasper.htm EX-10.17 25594
3 JASPER THERAPEUTICS, INC. INSIDER TRADING POLICY ea023178801ex19-1_jasper.htm EX-19.1 125753
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea023178801ex23-1_jasper.htm EX-23.1 1494
5 CERTIFICATION ea023178801ex31-1_jasper.htm EX-31.1 11497
6 CERTIFICATION ea023178801ex31-2_jasper.htm EX-31.2 10018
7 CERTIFICATION ea023178801ex32-1_jasper.htm EX-32.1 7138
8 GRAPHIC image_001.jpg GRAPHIC 24665
9 GRAPHIC image_002.jpg GRAPHIC 54670
10 GRAPHIC image_003.jpg GRAPHIC 25989
11 GRAPHIC image_004.jpg GRAPHIC 28002
12 GRAPHIC image_005.jpg GRAPHIC 19349
  Complete submission text file 0001213900-25-018384.txt   8179067

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE jspr-20241231.xsd EX-101.SCH 62627
14 XBRL CALCULATION FILE jspr-20241231_cal.xml EX-101.CAL 49842
15 XBRL DEFINITION FILE jspr-20241231_def.xml EX-101.DEF 308946
16 XBRL LABEL FILE jspr-20241231_lab.xml EX-101.LAB 587623
17 XBRL PRESENTATION FILE jspr-20241231_pre.xml EX-101.PRE 326867
95 EXTRACTED XBRL INSTANCE DOCUMENT ea0231788-10k_jasper_htm.xml XML 719653
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39138 | Film No.: 25683220
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)